177 related articles for article (PubMed ID: 21850053)
21. A Regulatory Element Near the 3' End of the Adeno-Associated Virus rep Gene Inhibits Adenovirus Replication in cis by Means of p40 Promoter-Associated Short Transcripts.
Weger S; Hammer E; Gonsior M; Stutika C; Heilbronn R
J Virol; 2016 Apr; 90(8):3981-93. PubMed ID: 26842470
[TBL] [Abstract][Full Text] [Related]
22. Herpes Simplex Virus 1 Coinfection Modifies Adeno-associated Virus Genome End Recombination.
Meier AF; Tobler K; Michaelsen K; Vogt B; Henckaerts E; Fraefel C
J Virol; 2021 Jun; 95(13):e0048621. PubMed ID: 33853961
[TBL] [Abstract][Full Text] [Related]
23. Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins.
Weger S; Wistuba A; Grimm D; Kleinschmidt JA
J Virol; 1997 Nov; 71(11):8437-47. PubMed ID: 9343200
[TBL] [Abstract][Full Text] [Related]
24. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
25. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.
Grimm D; Kay MA; Kleinschmidt JA
Mol Ther; 2003 Jun; 7(6):839-50. PubMed ID: 12788658
[TBL] [Abstract][Full Text] [Related]
26. Helper functions required for wild type and recombinant adeno-associated virus growth.
Geoffroy MC; Salvetti A
Curr Gene Ther; 2005 Jun; 5(3):265-71. PubMed ID: 15975004
[TBL] [Abstract][Full Text] [Related]
27. Molecular design of controllable recombinant adeno-associated virus (AAV) expression systems for enhanced vector production.
Johari YB; Pohle TH; Whitehead J; Scarrott JM; Liu P; Mayer A; James DC
Biotechnol J; 2024 Jun; 19(6):e2300685. PubMed ID: 38900035
[TBL] [Abstract][Full Text] [Related]
28. Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences.
Shi S; Mercer SA; Dilley R; Trippel SB
Virol J; 2009 Jan; 6():3. PubMed ID: 19128486
[TBL] [Abstract][Full Text] [Related]
29. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
30. Latent infection of KB cells with adeno-associated virus type 2.
Laughlin CA; Cardellichio CB; Coon HC
J Virol; 1986 Nov; 60(2):515-24. PubMed ID: 3021985
[TBL] [Abstract][Full Text] [Related]
31. Replication competent helper functions for recombinant AAV vector generation.
Cao L; During M; Xiao W
Gene Ther; 2002 Sep; 9(18):1199-206. PubMed ID: 12215886
[TBL] [Abstract][Full Text] [Related]
32. Differential contribution of adeno-associated virus type 2 Rep protein expression and nucleic acid elements to inhibition of adenoviral replication in cis and in trans.
Weger S; Hammer E; Heilbronn R
J Virol; 2014 Dec; 88(24):14126-37. PubMed ID: 25275117
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Hubert WG; Laimins LA
J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
[TBL] [Abstract][Full Text] [Related]
34. Definition of herpes simplex virus helper functions for the replication of adeno-associated virus type 5.
Stutika C; Hüser D; Weger S; Rutz N; Heßler M; Heilbronn R
J Gen Virol; 2015 Apr; 96(Pt 4):840-850. PubMed ID: 25535322
[TBL] [Abstract][Full Text] [Related]
35. Human Bocavirus 1 Is a Novel Helper for Adeno-associated Virus Replication.
Wang Z; Deng X; Zou W; Engelhardt JF; Yan Z; Qiu J
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659483
[TBL] [Abstract][Full Text] [Related]
36. Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events.
Alazard-Dany N; Nicolas A; Ploquin A; Strasser R; Greco A; Epstein AL; Fraefel C; Salvetti A
PLoS Pathog; 2009 Mar; 5(3):e1000340. PubMed ID: 19282980
[TBL] [Abstract][Full Text] [Related]
37. Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.
Kube DM; Ponnazhagan S; Srivastava A
J Virol; 1997 Oct; 71(10):7361-71. PubMed ID: 9311814
[TBL] [Abstract][Full Text] [Related]
38. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery.
Wang Q; Dong B; Firrman J; Roberts S; Moore AR; Cao W; Diao Y; Kapranov P; Xu R; Xiao W
Hum Gene Ther Methods; 2014 Aug; 25(4):261-8. PubMed ID: 25093498
[TBL] [Abstract][Full Text] [Related]
39. Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap.
Gao GP; Lu F; Sanmiguel JC; Tran PT; Abbas Z; Lynd KS; Marsh J; Spinner NB; Wilson JM
Mol Ther; 2002 May; 5(5 Pt 1):644-9. PubMed ID: 11991756
[TBL] [Abstract][Full Text] [Related]
40. High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant.
Hölscher C; Kleinschmidt JA; Bürkle A
J Virol; 1995 Nov; 69(11):6880-5. PubMed ID: 7474103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
